Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology

Immunological Investigations

Volumn 29, Issue 2, 2000, Pages 97-100

  Tortorella, Domenico ^a   Gewurz, Benjamin ^a   Schust, Danny ^a   Furman, Margo ^a   Ploegh, Hidde ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALNEXIN; CALRETICULIN; CD8 ANTIGEN; CHAPERONE; GENE PRODUCT; GLUCAN SYNTHASE; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OXIDOREDUCTASE; PEPTIDE; PROTEASOME; TAPASIN;

ANTIGEN PRESENTATION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE SYSTEM; PRIORITY JOURNAL; TUMOR; TUMOR IMMUNOLOGY;

EID: 0034106633     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.3109/08820130009062289     Document Type: Conference Paper

References (16)

1. Heemels, M. T., H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem. 64: 463-91
2. Rock, K. L., A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol. 17: 739-79
3. Fruh, K., A. Gruhler, R. M. Krishna, G. J. Schoenhals. 1999. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway [In Process Citation]. Immunol Rev. 168: 157-66
4. Townsend, A., H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol. 7: 601-24
5. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science. 280: 248-53
6. Ruiz-Cabello, F., F. Garrido. 1998. HLA and cancer: from research to clinical impact. Immunol Today. 19: 539-42
7. Jones, T. R., L. K. Hanson, L. Sun, J. S. Slater, R. M. Stenberg, A. E. Campbell. 1995. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibilily complex class I heavy chains. J Virol. 69: 4830-41
8. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84: 769-79
9. Wiertz, E. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones, T. A. Rapoport, H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction [see comments]. Nature. 384: 432-8
10. Tortorella, D., C. M. Story, J. B. Huppa, E. J. Wiertz, T. R. Jones, I. Bacik, J. R. Bennink, J. W. Yewdell, H. L. Ploegh. 1998. Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential [published erratum appears in J Cell Biol 1999 May 3;145(3):following 642]. J Cell Biol. 142: 365-76
11. Plemper, R. K., D. H. Wolf. 1999. Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem Sci. 24: 266-70
12. Schust, D. J., D. Tortorella, J. Seebach, C. Phan, H. L. Ploegh. 1998. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med. 188: 497-503
13. Machold, R. P., E. J. Wiertz, T. R. Jones, H. L. Ploegh. 1997. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med. 185: 363-6
14. Bankier, A. T., S. Beck, R. Bohni, C. M. Brown, R. Cerny, M. S. Chee, C. A. d. Hutchison, T. Kouzarides, J. A. Martignetti, E. Preddie, et al. 1991. The DNA sequence of the human cytomegalovirus genome. DNA Seq. 2: 1-12
15. Story, C. M., M. H. Furman, H. L. Ploegh. 1999. The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products. Proc Natl Acad Sci U S A. 96: 8516-21
16. Shamu, C. E., C. M. Story, T. A. Rapoport, H. L. Ploegh. 1999. The Pathway of US11-dependent Degradation of MHC Class I Heavy Chains Involves a Ubiquitin-conjugated Intermediate. J Cell Biol. 147: 45-58